Literature DB >> 31737192

LncRNA LOXL1-AS1 promotes invasion and proliferation of non-small-cell lung cancer through targeting miR-324-3p.

Ning Xie1, Xiuqu Fei1, Shuliang Liu1, Jie Liao1, Youjie Li2.   

Abstract

LncRNAs are played crucial roles in athogenesis of NSCLC. LOXL1-AS1 involved in development of several tumors. So far, there is no study about expression and function pattern of the LOXL1-AS1 in NSCLC. In this reference, we firstly proved that LOXL1-AS1 was overexpressed in NSCLC cell lines (H23, A549, H1299 and SPC-A1) compared to 16HBE cell. The expression of LOXL1-AS1 was overexpressed in NSCLC specimens than adjacent control specimens. We found that 29 of 40 cases showed higher LOXL1-AS1 expression in NSCLC samples as compared to adjacent control specimens. Ectopic expression of LOXL1-AS1 promoted H1299 cell and H23 cell proliferation. LOXL1-AS1 overexpression promoted ki-67 and cyclin D1 expression in the NSCLC cell. Overexpression of LOXL1-AS1 promoted cell invasion and induced N-cadherin and Vimentin expression and suppressed E-cadherin expression in the NSCLC cell. LOXL1-AS1 acts as one sponge for miR-324-3p in NSCLC cell. Moreover, the expression of miR-324-3p was lower in NSCLC specimens than adjacent control specimens. We found that 24 of 40 cases showed lower miR-324-3p expression in NSCLC samples as compared to adjacent control specimens. Further correlation assay indicated a negative association between miR-324-3p and LOXL1-AS1 expression. miR-324-3p restoration attenuates the function of LOXL1-AS1 overexpression on NSCLC cell. These results indicated that LOXL1-AS1 enhanced NSCLC cell proliferation and invasion via sponging miR-324-3p in NSCLC cell. AJTR
Copyright © 2019.

Entities:  

Keywords:  LOXL1-AS1; Non-small cell lung cancer; lncRNA; miR-324-3p

Year:  2019        PMID: 31737192      PMCID: PMC6834493     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  42 in total

1.  miR-342-3p targets RAP2B to suppress proliferation and invasion of non-small cell lung cancer cells.

Authors:  Xiao Xie; Hongtao Liu; Mingsong Wang; Fangbao Ding; Haibo Xiao; Fengqing Hu; Rui Hu; Ju Mei
Journal:  Tumour Biol       Date:  2015-02-09

2.  LncRNA MALAT1 promotes migration and invasion of non-small-cell lung cancer by targeting miR-206 and activating Akt/mTOR signaling.

Authors:  Yi Tang; GaoMing Xiao; YueJun Chen; Yu Deng
Journal:  Anticancer Drugs       Date:  2018-09       Impact factor: 2.248

3.  Long noncoding RNA CRNDE activates Wnt/β-catenin signaling pathway through acting as a molecular sponge of microRNA-136 in human breast cancer.

Authors:  Jinliang Huan; Li Xing; Qianhuang Lin; Hu Xui; Xianju Qin
Journal:  Am J Transl Res       Date:  2017-04-15       Impact factor: 4.060

Review 4.  Long non-coding RNAs in nucleus pulposus cell function and intervertebral disc degeneration.

Authors:  Zheng Li; Xingye Li; Chong Chen; Shugang Li; Jianxiong Shen; Gary Tse; Matthew T V Chan; William K K Wu
Journal:  Cell Prolif       Date:  2018-07-24       Impact factor: 6.831

5.  Long noncoding RNA LOXL1-AS1 regulates prostate cancer cell proliferation and cell cycle progression through miR-541-3p and CCND1.

Authors:  Bo Long; Na Li; Xi-Xia Xu; Xiao-Xin Li; Xin-Jie Xu; Jie-Ying Liu; Zhi-Hong Wu
Journal:  Biochem Biophys Res Commun       Date:  2018-09-29       Impact factor: 3.575

6.  Long non-coding RNA MEG3 inhibits microRNA-125a-5p expression and induces immune imbalance of Treg/Th17 in immune thrombocytopenic purpura.

Authors:  Jian-Qin Li; Shao-Yan Hu; Zhao-Yue Wang; Jing Lin; Su Jian; Yong-Chao Dong; Xiao-Fang Wu; Li-Juan Cao
Journal:  Biomed Pharmacother       Date:  2016-08-10       Impact factor: 6.529

7.  MiR-96 downregulates RECK to promote growth and motility of non-small cell lung cancer cells.

Authors:  Haizhou Guo; Qianping Li; Weihao Li; Tianliang Zheng; Song Zhao; Zhangsuo Liu
Journal:  Mol Cell Biochem       Date:  2014-01-29       Impact factor: 3.396

8.  Long non-coding RNA ANRIL is up-regulated in bladder cancer and regulates bladder cancer cell proliferation and apoptosis through the intrinsic pathway.

Authors:  Hongxue Zhu; Xuechao Li; Yarong Song; Peng Zhang; Yajun Xiao; Yifei Xing
Journal:  Biochem Biophys Res Commun       Date:  2015-10-09       Impact factor: 3.575

9.  By downregulating Ku80, hsa-miR-526b suppresses non-small cell lung cancer.

Authors:  Zun-yi Zhang; Sheng-ling Fu; Su-qin Xu; Xiao Zhou; Xian-shen Liu; Yong-jian Xu; Jian-ping Zhao; Shuang Wei
Journal:  Oncotarget       Date:  2015-01-30

10.  LncRNA LINC01512 Promotes the Progression and Enhances Oncogenic Ability of Lung Adenocarcinoma.

Authors:  Jie Chen; Fan Zhang; Junjun Wang; Lijuan Hu; Jian Chen; Gang Xu; Yumin Wang
Journal:  J Cell Biochem       Date:  2017-06-22       Impact factor: 4.429

View more
  10 in total

1.  LncRNA LOXL1-AS1 Facilitates the Oncogenic Character in Cervical Cancer by the miR-526b-5p /LYPLA1 Axis.

Authors:  Yanhua Zhang; Meng Zheng; Lingyan Zhang; Ping Yuan; Jianbo Zhou; Yongfang Wang; Haihong Wang
Journal:  Biochem Genet       Date:  2022-01-04       Impact factor: 2.220

2.  Long Non-Coding RNA LOXL1-AS1 Enhances Colorectal Cancer Proliferation, Migration and Invasion Through miR-708-5p/CD44-EGFR Axis.

Authors:  Xiaoyu Wu; Facai Cui; Yu Chen; Ya Zhu; Fengzhen Liu
Journal:  Onco Targets Ther       Date:  2020-08-03       Impact factor: 4.147

3.  LOXL1-AS1 contributes to the proliferation and migration of laryngocarcinoma cells through miR-589-5p/TRAF6 axis.

Authors:  Guijun He; Wenfeng Yao; Liang Li; Yang Wu; Guojian Feng; Li Chen
Journal:  Cancer Cell Int       Date:  2020-10-13       Impact factor: 5.722

4.  LOXL1-AS1 communicating with TIAR modulates vasculogenic mimicry in glioma via regulation of the miR-374b-5p/MMP14 axis.

Authors:  Bolong Yi; Hao Li; Heng Cai; Xin Lou; Mingjun Yu; Zhen Li
Journal:  J Cell Mol Med       Date:  2021-12-08       Impact factor: 5.310

5.  Down-regulation of ZNF252P-AS1 alleviates ovarian cancer progression by binding miR-324-3p to downregulate LY6K.

Authors:  Li Geng; Zhongqiu Wang; Yongju Tian
Journal:  J Ovarian Res       Date:  2022-01-03       Impact factor: 4.234

6.  MiR-211-5p Inhibits the Biological Behaviors of Colorectal Cancer via SPARC-Related Growth Factor Pathways.

Authors:  Xiaoyu Wu; Yu Chen; Ya Zhu; Facai Cui
Journal:  J Cancer       Date:  2022-03-21       Impact factor: 4.207

Review 7.  Cell Behavior of Non-Small Cell Lung Cancer Is at EGFR and MicroRNAs Hands.

Authors:  Sarah Sayed Hassanein; Sherif Abdelaziz Ibrahim; Ahmed Lotfy Abdel-Mawgood
Journal:  Int J Mol Sci       Date:  2021-11-19       Impact factor: 5.923

Review 8.  A review on the role of miRNA-324 in various diseases.

Authors:  Sepideh Kadkhoda; Bashdar Mahmud Hussen; Solat Eslami; Soudeh Ghafouri-Fard
Journal:  Front Genet       Date:  2022-08-10       Impact factor: 4.772

9.  Inhibition of LOXL1-AS1 alleviates oxidative low-density lipoprotein induced angiogenesis via downregulation of miR-590-5p mediated KLF6/VEGF signaling pathway.

Authors:  Xuan Cheng; Zhiwei Liu; Haifeng Zhang; Yajun Lian
Journal:  Cell Cycle       Date:  2021-07-31       Impact factor: 5.173

10.  lncRNA LOXL1-AS1 promotes liver cancer cell proliferation and migration by regulating the miR-377-3p/NFIB axis.

Authors:  Wei Yu; Yong Dai
Journal:  Oncol Lett       Date:  2021-06-29       Impact factor: 2.967

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.